Dr Christine M. Friedenreich is a Canadian Cancer Society Board of Directors Member, former Scientific Chair of the Advisory Council on Research and a previous recipient of Canadian Cancer Society funding.

This year, the CCRA recognized her for her Exceptional Leadership in Cancer Research👏

And a third recipient with a connection to the Canadian Cancer Society is Dr Sevtap Savas who was recognized for her Exceptional Leadership in Patient Involvement in Cancer Research 👏

Dr Savas is a passionate advocate and Advocacy Constituency Team Lead with the Canadian Cancer Society💛

Huge congratulations to all of the award recipients for their incredible work in cancer research💛

Welcome! 👋 Happy to have you here!

As part of a @cancersociety.bsky.social Breakthrough Team Grant, Dr Goodarzi and a team of researchers from across Canada will continue this work with the goal of improving #LungCancer detection. Learn more here: is.gd/utku8b

Congratulations to our 2025 Workplace #Cancer #Research Grant recipients – and thank you for all you do to keep workers in Canada safe and healthy.

To learn more about these grants, visit our website: is.gd/WCRG2025

Outdoor workers are 3 times as likely to develop skin cancer as indoor workers. Dr @cherylepeters.bsky.social will use existing data to estimate the rates and costs of skin cancers caused by workplace sun exposure. The goal: to guide national efforts to reduce sun exposure and prevent future cases.

Dr Paul Demers will study the latest statistics to estimate how many work-related lung cancers are likely to arise in 2026 and how much they may cost workers and healthcare systems. He hopes this information will pave the way to better workplace #cancer awareness and prevention.

Many construction workers may be exposed to asbestos, which can cause lung cancer. It’s unclear how many undergo lung cancer screening or how their health and care compare to that of other construction workers. Dr Nathan DeBono aims to improve cancer prevention and screening for this at-risk group.

Cancer drugs can be toxic to healthy cells. Dr Hugh W. Davies will study how much contact healthcare workers have with these drugs in different environments and how the drugs may affect their health. His goal is to better understand the risk and make workplaces safer for healthcare professionals.

These grants are developed in close collaboration with labour unions and workers’ compensation boards. They bring #cancer researchers together to focus on preventing, detecting and treating work-related cancers – focusing on high-priority areas where we can make great strides.

These awards celebrate #researchers who exemplify excellence in #cancer #science and outstanding service to the scientific community. Winners receive a personalized plaque and $20,000 to support their research program.

For eligibility criteria and more information, go to cancer.ca/en/research/...

We are accepting nominations for the following categories:

CCS Lifetime Contribution Prize
CCS Inclusive Excellence Prize
CCS Robert L. Noble Prize
CCS O. Harold Warwick Prize
CCS Bernard and Francine Dorval Prize
CCS William E. Rawls Prize